ENST00000266732.8:c.1805A>G
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000266732.8(TMPO):c.1805A>G(p.Gln602Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000172 in 1,609,278 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000266732.8 missense
Scores
Clinical Significance
Conservation
Publications
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
- dilated cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMPO | NM_001032283.3 | c.565+2224A>G | intron_variant | Intron 3 of 8 | ENST00000556029.6 | NP_001027454.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000874 AC: 133AN: 152260Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000236 AC: 59AN: 250250 AF XY: 0.000163 show subpopulations
GnomAD4 exome AF: 0.0000968 AC: 141AN: 1456900Hom.: 0 Cov.: 32 AF XY: 0.0000746 AC XY: 54AN XY: 723520 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000886 AC: 135AN: 152378Hom.: 1 Cov.: 33 AF XY: 0.000939 AC XY: 70AN XY: 74512 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Gln602Arg in exon 4A of TMPO: This variant is not expected to have clinical sign ificance due to its frequency in the general population as well as a lack of evo lutionary conservation. It has been identified in 0.34% (15/4406) of African Ame rican chromosomes by the NHLBI Exome Sequencing Project and 2 mammals have an ar ginine (Arg) at this position despite high nearby amino acid conservation. -
- -
TMPO-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
- -
Loeys-Dietz syndrome 2 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at